期刊文献+

替米沙坦改善糖尿病大鼠肾脏功能机制研究 被引量:3

Modulation mechanism of kidney function by telmisartan in diabetic rats
在线阅读 下载PDF
导出
摘要 目的研究替米沙坦对糖尿病大鼠24 h尿蛋白、血肌酐、肌酐清除率(Ccr)和血清尿素氮(BUN)等相关代谢指标的影响,且应用基因芯片探讨替米沙坦改善肾功能的机制。方法 30只SD大鼠,其中随机选取10只为正常对照组(给予等体积生理盐水)。选用20只大鼠,采用STZ法制备糖尿病模型,而后将16只造模成功的糖尿病大鼠随机分为替米沙坦治疗组(给予10 mg/kg/d的替米沙坦,n=8)和糖尿病模型组(给予等体积生理盐水,n=8)。三组大鼠均连续灌胃12周。每4周测定大鼠空腹血糖(FBG)和体重。12周末测定大鼠24h尿蛋白、尿肌酐、血肌酐和BUN水平。12周末处死大鼠,取肾脏组织进行基因芯片实验,并运用real time PCR进行验证。结果糖尿病模型组24h尿蛋白(P<0.01)、血肌酐(P<0.05)和BUN(P<0.01)比对照组显著升高,Ccr较对照组显著降低(P<0.05)。替米沙坦能改善糖尿病大鼠24h尿蛋白、血肌酐、Ccr和BUN水平。基因芯片结果显示替米沙坦组较糖尿病模型组有1541个基因发生显著改变,其中554个上调,987个下调。基因富集分析显示这些差异表达基因集中在氧化磷酸化通路和PPAR通路。Real time PCR证实替米沙坦组较糖尿病模型组ATP合成酶β亚基(Atp5b)、细胞色素c氧化酶亚基VIc(Cox6c)和NADH脱氢酶(辅酶Q)铁硫蛋白3(Ndufs3)基因显著下调。结论替米沙坦能有效改善糖尿病大鼠肾脏功能。替米沙坦的肾脏改善作用可能是通过线粒体氧化磷酸化通路和PPAR-γ通路调节。 Objective To explore the effects of telmisartan on the kidney function in diabetic rats and to inves- tigate its possible mechanism. Methods SD rats were randomly divided into two groups: diabetic group ( n = 20) and control group (n = 10). The diabetic group was injected with streptozotoein (STZ). Diabetic rats were randomly divided into two groups: telmisartan group (treated with 10 mg./kg/d telmisartan, n = 8) and diabetic group (n = 8). The fasting blood glucose, body weight, 24-hour urinary protein, creatinine clearance rate (Ccr) , serum creatinine and blood urea ni- trogen (BUN) were tested. Gene expression in the rat renal tissues was assyed with microarray analysis. Results Telmis- arran significantly decreased 24-hour urinary albumin ( P 〈 0.01 ) , serum creatinine ( P 〈 0. 05 ) , BUN ( P 〈 0.01 ) , and increased Ccr ( P 〈 0. 05 ) , compared with those of the diabetic group. Microarray analysis showed that expressions of 1541 genes were significantly changed in the telmisartan group (554 increased, 987 decreased). Real-time PCR verified that ATP synthase beta subunit (ATP5b), eytoehrome c oxidase subunit Vic (Cox6c), and NADH dehydrogenase (ubiqui- none) Fe-S protein 3 (Ndufs3) were significantly down-regulated. Conclusion Telmisartan can improve kidney functionin diabetic rats. Mitochondria oxidative phosphorylation and PPAR-Y/pathway may be involved in the mechanism of action.
出处 《中国实验动物学报》 CAS CSCD 2012年第6期10-14,共5页 Acta Laboratorium Animalis Scientia Sinica
基金 北京协和医院基金项目(编号:2006119) 国家临床重点专科建设项目
关键词 替米沙坦 基因芯片 糖尿病 肾脏功能 Telmisartan Diabetes mellitus Rats Gene microarray Kidney function
  • 相关文献

参考文献9

  • 1Benndorf RA, Appel D, Maas R, et al. Telmisartan improves endothelial function in patients with essential hypertension [J]. J Cardiovasc Pharmacol, 2007, 50 (4) :367 - 371.
  • 2Bakris G, Burgess E, Weir M, et al. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy [J]. Kidney Int, 2008, 74(3):364-369.
  • 3Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 ( - delta delta C (T)) Method [J]. Methods, 2011, 25(4):402-408.
  • 4Nakamura T, Fujiwara N, Sato E, et al. Renoprotective effects of various angiotensin Ⅱ receptor blockers in patients with earlystage diabetic nephropathy [ J ]. Kidney Blood Pressure Res, 2010, 33(3) :213 -220.
  • 5Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study [ J]. Hypertension Res 2008, 31 (4) :657 -664.
  • 6Westermann B. Mitochondrial fusion and fission in cell life and death [J]. Nat Rev Mol Cell Biol, 2010, 11(12) :872 -884.
  • 7肖力,孙林,刘伏友.糖尿病肾脏疾病蛋白尿形成机制新进展[J].中华肾脏病杂志,2010,26(6):478-480. 被引量:16
  • 8Brownlee M. The pathobiology of diabetic complications: a unifying mechanism [J]. Diabetes, 2005, 54(6): 1615- 1625.
  • 9Yao Y, Zou R, Liu X, et al. Telmisartan but not valsartan inhibits TGF-β mediated accumulation of extracellular matrix via activation of PPART [ J ]. J Huazhong Univ Sci Technol ( Med Sci), 2008, 28(5) :543 -548.

二级参考文献29

  • 1Satchell SC,Tooke JE.What is the mechanism of microalbuminuria in diabetes:a role for the glomerular endothelium? Diabetologia,2008,51:714-725.
  • 2Kanwar YS,Akagi S,Sun L,et al.Cell biology of diabetic kidney disease.Nephron Exp Nephrol,2005,101:e100-e110.
  • 3Kanwar YS,Wada J,Sun L,et al.Diabetic nephropathy:mechanisms of renal disease progression.Exp Biol Med (Maywood),2008,233:4-11.
  • 4Hjalmarsson C,Johansson BR,Haraldsson B.Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries.Microvasc Res,2004,67:9-17.
  • 5Nieuwdorp M,Mooij HL,Kroon J,et al.Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes.Diabetes,2006,55:1127-1132.
  • 6Jeansson M,Haraldsson B.Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycandegrading enzymes.J Am Soc Nephrol,2003,14:1756-1765.
  • 7Satchell SC,Tasman CH,Singh A,et al.Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF.Kidney Int,2006,69:1633-1640.
  • 8De Vriese AS,Tilton RG,Elger M,et al.Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.J Am Soc Nephrol,2001,12:993-1000.
  • 9Segev Y,Eshet R,Yakir O,et al.Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.Diabetologia,2007,50:1327-1334.
  • 10Segev Y,Eshet R,Rivkis I,et al.Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.Nephrol Dial Transplant,2004,19:3021-3028.

共引文献15

同被引文献25

  • 1Nobuyuki K,Hiroshi K.Effects of pimobendan for mitral valve regurgitation in dogs[J].The Journal of veterinary medical science / the Japanese Society of Veterinary Science,2007,69(4):136-138.
  • 2Cauthen CA,Lipinski MJ,Abbate A.Relation of blood urea nitrogen to long-term mortality in patients with heart failure[J].The American Journal of Cardiology,2008,101 (11):134-136.
  • 3Bridget K,Urie DM,Christopher M.Evaluation of clinical status,renal function,and hematopoietic variables after unilateral nephrectomy in canine kidney donors[J].Journal of the American Veterinary Medical Association,2007,230(11):245-247.
  • 4Srinivasan S, Spear J, Chandran K, et al. Oxidative slress induced mitochondrial protein kinase A medi- ates cytochrome c oxidase dysfunction[J]. PLoS One, 2013,8(10) : e77129.
  • 5Kar AN, Sun CY, Reichard K, et al. Dysregulation of the axonal trafficking of nuclear-encoded mito- chondrial mRNA alters neuronal mitochondrial activi- ty and mouse behavior[J]. Dev Neurobio1,2014,74 (3) : 333-350.
  • 6Sun JH, Nan LH, Gao CR, et al. Validation of ref- erence genes for estimating wound age in contused rat skeletal muscle by quantitative real-time PCR[J]. Int J Legal Med,2012,126(1):113-120.
  • 7Sun JH, Wang YY, Zhang L, et al. Time-dependent expression of skeletal muscle troponin I mRNA in the euntused skeletal muscle of rats: a possible marker for wound age estimation[J]. Int J Legal Med, 2010,124(1) :27-33.
  • 8Cecchi R. Estimating wound age: looking into the future[J]. Int J Legal Med,2010,124(6):523-536.
  • 9Kondo T, Ishida Y. Molecular pathology of wound healing[J]. Forensic Sci Int, 2010,203 ( 1-3 ) : 93 -98.
  • 10Masha RT, Houreld NN, Abrahamse H. Low-inten- sity laser irradiation at 660 nm stimulates transcrip- tion of genes involved in the electron transport chain[J]. Photomed Laser Surg,2013,31 (2) :47-53.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部